Page 3 - Medicalcare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing.

City ofUnited kingdomAntonio bertolettiProgramme in emerging infectious diseases atStefano lo prioreIsabella della noceChief biologistProfessor antonio bertolettiEmerging infectious diseasesHyris systemCovid 19Eneticanalysis immunologyT cell